Cargando…
International platform trials: as diseases cross borders, so should trials
Autor principal: | Saito, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036126/ https://www.ncbi.nlm.nih.gov/pubmed/36966801 http://dx.doi.org/10.1016/S1473-3099(23)00193-7 |
Ejemplares similares
-
Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemic
por: Tan, A.C., et al.
Publicado: (2022) -
Legitimacy in international law of Australian border closure to own citizens
por: Boretti, A.
Publicado: (2022) -
Platform Trials — Beware the Noncomparable Control Group
por: Dodd, Lori E., et al.
Publicado: (2021) -
Research on agroforestry systems and biodiversity conservation: what can we conclude so far and what should we improve?
por: Boinot, Sébastien, et al.
Publicado: (2022) -
Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy
por: Yamin, Dan, et al.
Publicado: (2021)